Uzbekistan Tightens Requirements for Classifying Medicines as Over-the-Counter
Uzbekistan has amended the procedure for recognizing medicines as over-the-counter: safety, side effects, and the risk of improper use will now be considered in the evaluation.

On November 12, the Ministry of Justice of Uzbekistan registered changes to the rules for classifying medicines as over-the-counter. When making a decision, authorities will now assess the likelihood of exceeding the recommended dosage, misuse of the drug, and the risk of dependency.
Experts will also evaluate how clear the instructions are for self-administration and whether there is sufficient data on the medicine's safety. Over-the-counter status may be granted to drugs containing two or more active substances. For these, the compatibility of components, their specific effects, and the balance between expected benefits and potential risks will be additionally studied.
The procedure for resubmitting documents has also changed. If an applicant was previously denied reclassification of a drug as over-the-counter, they may reapply before the three-year period expires. To do so, they must address the reasons for refusal or provide new information confirming the medicine's safety and efficacy.
The authorized body has been granted the authority to review a drug's classification if new scientific data, pharmacovigilance results, or changes in legislation emerge.




